Chairman, Legal Representative of TTY Biopharm Co. Ltd
Mr. Suen is the advisor of TTY Biopharm Co., Ltd. and was previously the General Manager of China Development Industrial Bank, the largest VC for biotech in Taiwan. He received his MBA at Young America City State University in the US.
Legal Representative of the National Development Fund, Executive Yuan
Dr. Huang is the distinguished professor at the Institute of Biopharmaceutical Sciences, and has joint appointments at the Institute of Clinical Medicine, Institute of Biomedical Informatics and Department of Biotechnology and Laboratory Science in Medicine, National Yang Ming University. He served as the chairman at the Institute of Biopharmaceutical Sciences. He has placed two cancer stem cell inhibitors in phase 1 and phase 2 clinical trials, respectively. He received his Ph.D. in Biochemistry at Iowa State University and postdoc training at Stanford University, USA.
Mr. Wu is Special Assistant of General manager, TTY Biopharm Co., Ltd. and was previously Supervisor of CY Biotech Company Limited. He received his master in Department of Law at Chinese Culture University, Taipei, Taiwan.
Dr. Yeh was the Founder, President and CEO of PharmaEngine from 2003-2019. She worked in academic research in England and France, as well as in drug discovery and development at T Cell Sciences, CytoMed, LeukoSite, and Millennium Pharmaceuticals in Cambridge, MA, USA. She received her Ph.D. in Immunology at the Medical University of South Carolina, Charleston, SC, USA
Ms. Su was previously the President of Taipei Exchange and Secretary General of Financial Supervisory Commission R.O.C. (Taiwan). She received her master in Local Economic Development from the London School of Economics and Political Science, UK.